Lasofoxifene does not affect cognitive function in postmenopausal women: Results from two Phase 3 randomized controlled clinical trials for osteoporosis prevention

被引：0
|
作者：
Yaffe, K
Petrie, CD
Radecki, D
Modelska, K
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Pfizer Inc, Groton, CT 06340 USA
[3] Chiron Corp, Emeryville, CA 94608 USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2005年 / 53卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Lasofoxifene does not affect cognitive function in postmenopausal women: Results from two phase 3 randomized controlled clinical trials for osteoporosis prevention
    Yaffe, K
    Petrie, C
    Radecki, D
    Modelska, K
    NEUROLOGY, 2005, 64 (06) : A145 - A145
  • [2] Endometrial effects of lasofoxifene: Results from two phase 3 osteoporosis prevention trials
    Goldstein, Steven R.
    Portman, David
    Symons, James
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1372 - 1372
  • [3] Oral lasofoxifene's effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials
    Kagan, Risa
    Simon, James A.
    Goldstein, Steven R.
    Komm, Barry S.
    Jenkins, Simon N.
    Portman, David J.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (06): : 494 - 504
  • [4] Risedronate for the Prevention and Treatment of Postmenopausal Osteoporosis: Results From Recent Clinical Trials
    N. B. Watts
    Osteoporosis International, 2001, 12 (Suppl 3) : S17 - S22
  • [5] Risedronate for the prevention and treatment of postmenopausal osteoporosis: Results from recent clinical trials
    Watts, NB
    OSTEOPOROSIS INTERNATIONAL, 2001, 12 : 17 - 22
  • [6] Lasofoxifene prevents postmenopausal bone loss: Pooled data from two pivotal 24 month osteoporosis prevention trials
    Kagan, Risa
    Symons, James
    Portman, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (12): : 1374 - 1374
  • [7] Teriparatide and Raloxifene Reduce the Risk of New Adjacent Vertebral Fractures in Postmenopausal Women with Osteoporosis Results from Two Randomized Controlled Trials
    Bouxsein, Mary L.
    Chen, Peiqi
    Glass, Emmett V.
    Kallmes, David F.
    Delmas, Pierre D.
    Mitlak, Bruce H.
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2009, 91A (06): : 1329 - 1338
  • [8] Unopposed estradiol therapy in postmenopausal women - Results from two randomized trials
    Steiner, Anne Z.
    Xiang, Min
    Mack, Wendy J.
    Shoupe, Donna
    Felix, Juan C.
    Lobo, Rogerio A.
    Hodis, Howard N.
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (03): : 581 - 587
  • [9] Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials
    Z.-B. Huang
    S.-L. Wan
    Y.-J. Lu
    L. Ning
    C. Liu
    S.-W. Fan
    Osteoporosis International, 2015, 26 : 1175 - 1186
  • [10] Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials
    Huang, Z. -B.
    Wan, S. -L.
    Lu, Y. -J.
    Ning, L.
    Liu, C.
    Fan, S. -W.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (03) : 1175 - 1186
12345